News

• OHRP COVID-19 Guidance (2020)
• Updated FDA Guidance for COVID19 (2020)
• Notification to Clients: COVID-19 Policy Exception Statement (2020)
• FDA Guidance March 2020 Clinical Trial Conduct during COVID-19 (2020)
• COVID-19 Instructions for Clients (2020)
• Versiti acquires Texas-based Cenetron Central Laboratories and Salus IRB to advance clinical trial capabilities (2019)
• Salus IRB Announces Name Change (2014)
• Salus IRB Announces Addition of Third Review Board (2013)
• Salus IRB Celebrates 25 Years of Trusted Service (2010)
• Salus IRB Launches SafeSync Online Submissions (2010)
• Salus IRB Announces DHHS Research Oversight (2009)
• Salus IRB Receives Full Accreditation from AAHRPP (2009)
• Salus IRB Announces Launch of GlobeSync Virtual Workspace (2009)
• Cenetron Diagnostics Announces the Acquisition of Salus IRB (2008)

© 2020 Salus IRB All Rights Reserved.   •   Salus IRB   •   2111 West Braker Lane, Suite 100   •   Austin, TX 78758